Search | TVST | ARVO Journals

Showing 1 – 20 of 23

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2023

The Characterization of the Ang-2 Arm of a Novel Anti-VEGF-A and Ang-2 Bispecific Protein (RO-101) in Comparison to Faricimab-svoa

Megana Paidela; Li Xu; Parth Patel; John Mitchell Kunzeman; Jessi Prentice; Robert Lowenthal; Mark Barakat; Arshad M. Khanani; Peter K Kaiser; Jeffrey L. Olson; Jeffrey S Heier; Ramanath Bhandari

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):739.

ARVO Annual Meeting Abstract June 2023

Binding Characteristics of the VEGF Arm of a Novel Bispecific Protein RO-101 in Comparison to Faricimab-svoa

Parth Patel; Li Xu; Megana Paidela; John Mitchell Kunzeman; Jessi Prentice; Mark Barakat; Robert Lowenthal; Arshad M. Khanani; Peter M Kaiser; Jeffrey S Heier; Jeffrey L. Olson; Ramanath Bhandari

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):738.

ARVO Annual Meeting Abstract June 2022

ASCORBIC ACID ATTENUATES HYDROGEN PEROXIDE INDUCED OXIDATIVE STRESS AND OSTEOBLASTS DEMONSTRATE ANTIOXIDANT RECYCLING POTENTIAL

Richard Tran; Joshua Morgenstern; Steven Droho; Jeffrey L Olson

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):375 – F0206.

ARVO Annual Meeting Abstract June 2022

Characterizing a Novel Bispecific Platform (Surrobody) for use in Back of the Eye Disease

Ramanath Bhandari; Li Xu; Evan Sembell; Jeffrey L Olson; Peter M Kaiser; Arshad M. Khanani; Jeffrey S Heier; Alina Sinha; John M Kunzeman; Nikhil Gupta; Ramesh Bhatt

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):302 – F0105.

ARVO Annual Meeting Abstract June 2022

Determining the Ocular Biocompatibility of a Novel VEGF-A and Ang-2 Bispecific Protein (RO-634) Through Histological Analysis

Evan Sembell; Jeffrey L Olson; Anthony Jones; Josh Morgenstern; Anne Strong; Steven Droho; Niklaus Mueller; Michael Huvard; Shaun Bevers; Li Xu; Peter K Kaiser; Arshad M. Khanani; Jeffrey S Heier; Nikhil Gupta; John M Kunzeman; Ramanath Bhandari

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):305 – F0108.

ARVO Annual Meeting Abstract June 2022

Preclinical Animal Model for Functional Biocompatibility of a Novel VEGF and Ang-2 Bispecific Protein (RO-634) Using ERG Analysis

Nikhil Gupta; Jeffrey L Olson; Anthony Jones; Josh Morgenstern; Anne Strong; Steven Droho; Shaun Bevers; Niklaus Mueller; Michael Huvard; Li Xu; Peter K Kaiser; Arshad M. Khanani; Jeffrey S Heier; Alina Sinha; Evan Sembell; Ramanath Bhandari

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):286 – F0089.

ARVO Annual Meeting Abstract June 2022

RO-634 half-life as compared to published data on Aflibercept, Faricimab, Ranibizumab, and Bevacizumab.

Zafar Gill; Jeffrey L Olson; Josh Morgenstern; Anthony Jones; Anne Strong; Steven Droho; Shaun Bevers; Niklaus Mueller; Nihaal Mehta; Michael Huvard; Peter K Kaiser; Ramanath Bhandari

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):308 – F0111.

ARVO Annual Meeting Abstract June 2022

The Half Maximal Effective Concentration (EC50) of a Novel VEGF-A and Ang-2 Bispecific Protein (RO-634) for Back of the Eye Disease

Alina Sinha; Jeffrey L Olson; Anthony Jones; Josh Morgenstern; Anne Strong; Steven Droho; Shaun Bevers; Niklaus Mueller; Michael Huvard; Li Xu; Peter K Kaiser; Arshad M. Khanani; Jeffrey S Heier; John M Kunzeman; Evan Sembell; Ramanath Bhandari

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1316 – F0150.

ARVO Annual Meeting Abstract June 2022

Assessing Inhibition of HUVEC Migration by a Novel VEGF-A and Angiopoietin-2 Bispecific Protein (RO-634)

John Kunzeman; Jeffrey L Olson; Anthony Jones; Josh Morgenstern; Anne Strong; Steven Droho; Shaun Bevers; Niklaus Mueller; Michael Huvard; Li Xu; Peter K Kaiser; Arshad M. Khanani; Jeffrey S Heier; Nikhil Gupta; Alina Sinha; Ramanath Bhandari

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1325 – F0159.

ARVO Annual Meeting Abstract June 2020

RPE cellular morphology and intracellular autofluorescence after suppression of vitreous complement levels

Anthony Jones; Joshua Logan Morgenstern; Jeffrey L Olson

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):318.

ARVO Annual Meeting Abstract June 2020

Polyacrylonitrile implant prevents retinal photoreceptor degeneration in a mouse model of AMD

Joshua L Morgenstern; Anthony Jones; Anne D Strong; Ellen Rhodes; Eric R Williams; Jeffrey L Olson

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):322.

Articles November 2014

Laser Activated Flow Regulator for Glaucoma Drainage Devices

PDF

Jeffrey L. Olson; Raul Velez-Montoya; Ramanath Bhandari
TAGS: fluid flow, glaucoma drainage implants, lasers
Trans. Vis. Sci. Tech.. 2014; 3(6):3. https://doi.org/10.1167/tvst.3.6.3

ARVO Annual Meeting Abstract April 2014

Successful Globe Salvage In "Inoperable" Rhegmatogenous Retinal Detachment: Retrospective Study Of Ten Cases

Hugo Quiroz-Mercado; Guillermo Salcedo; Jeffrey L Olson; Naresh Mandava; Scott C Oliver

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1125.

ARVO Annual Meeting Abstract April 2014

Spectral Domain Optical Coherence Tomographic Analysis Of Non-Occluded Retina in Branch Retinal Vein Occlusion And Its Response to Anti-angiogenic Therapy

Guillermo Salcedo; Mariana Harasawa; Raul Velez-Montoya; Marc T Mathias; Frank S Siringo; Jeffrey L Olson; Scott C Oliver; Naresh Mandava; Hugo Quiroz-Mercado

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1935.

ARVO Annual Meeting Abstract April 2014

Measurement of progression of Gyrate Atrophy using Ultra-Wide Field fundus photography

Miguel Paciuc-Beja; Guillermo Salcedo; Jesse M Smith; Mariana Harasawa; Raul Velez-Montoya; Jeffrey L Olson; Scott C Oliver; Naresh Mandava; Hugo Quiroz-Mercado

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):265.

ARVO Annual Meeting Abstract April 2014

Spectral Domain Optical Coherence Tomographic Analysis Of The Ocular Equator

Mariana Harasawa; Guillermo Salcedo; Miguel Paciuc-Beja; Marc T Mathias; Raul Velez-Montoya; Jeffrey L Olson; Scott C Oliver; Naresh Mandava; Hugo Quiroz-Mercado

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3394.

Nantotechnology and Regenerative Medicine August 2012

Intravitreal Silicon-Based Quantum Dots as Neuroprotective Factors in a Model of Retinal Photoreceptor Degeneration

PDF

Jeffrey L. Olson; Raul Velez-Montoya; Naresh Mandava; Conrad R. Stoldt
TAGS: photoreceptors, quantum dots, retina, silicon, tissue degeneration
Invest. Ophthalmol. Vis. Sci.. 2012; 53(9):5713-5721. https://doi.org/10.1167/iovs.12-9745

ARVO Annual Meeting Abstract March 2012

Non-mydriatic Single Filed Fundus Camera For Diabetic Retinopathy Screening: Assessment Of Efficacy, Prevalence And Risk Factors In A Safety Net Institution

Shulamit Schwartz; Valeria Baldivieso; Allison L. Sabel; Naresh Mandava; Scott N. Oliver; Jeffrey L. Olson; Hugo Quiroz-Mercado

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2891.

ARVO Annual Meeting Abstract March 2012

Quantum Dots As Neuroprotective Factor In A Model Of Retinal Photoreceptor Degeneration

Raul Velez-Montoya; Naresh Mandava; Conrad R. Stoldt; Jeffrey L. Olson

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):6422.

Lens January 2012

Ocular Biocompatibility of Nitinol Intraocular Clips

PDF

Jeffrey L. Olson; Raul Velez-Montoya; Michael Erlanger
TAGS: biocompatibility, intraocular surgical clips, nitinol, surgical procedures, operative, sutures, eye, cornea, electroretinography
Invest. Ophthalmol. Vis. Sci.. 2012; 53(1):354-360. https://doi.org/10.1167/iovs.11-8496

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

The Characterization of the Ang-2 Arm of a Novel Anti-VEGF-A and Ang-2 Bispecific Protein (RO-101) in Comparison to Faricimab-svoa

Binding Characteristics of the VEGF Arm of a Novel Bispecific Protein RO-101 in Comparison to Faricimab-svoa

ASCORBIC ACID ATTENUATES HYDROGEN PEROXIDE INDUCED OXIDATIVE STRESS AND OSTEOBLASTS DEMONSTRATE ANTIOXIDANT RECYCLING POTENTIAL

Characterizing a Novel Bispecific Platform (Surrobody) for use in Back of the Eye Disease

Determining the Ocular Biocompatibility of a Novel VEGF-A and Ang-2 Bispecific Protein (RO-634) Through Histological Analysis

Preclinical Animal Model for Functional Biocompatibility of a Novel VEGF and Ang-2 Bispecific Protein (RO-634) Using ERG Analysis

RO-634 half-life as compared to published data on Aflibercept, Faricimab, Ranibizumab, and Bevacizumab.

The Half Maximal Effective Concentration (EC50) of a Novel VEGF-A and Ang-2 Bispecific Protein (RO-634) for Back of the Eye Disease

Assessing Inhibition of HUVEC Migration by a Novel VEGF-A and Angiopoietin-2 Bispecific Protein (RO-634)

RPE cellular morphology and intracellular autofluorescence after suppression of vitreous complement levels

Polyacrylonitrile implant prevents retinal photoreceptor degeneration in a mouse model of AMD

Laser Activated Flow Regulator for Glaucoma Drainage Devices

Successful Globe Salvage In "Inoperable" Rhegmatogenous Retinal Detachment: Retrospective Study Of Ten Cases

Spectral Domain Optical Coherence Tomographic Analysis Of Non-Occluded Retina in Branch Retinal Vein Occlusion And Its Response to Anti-angiogenic Therapy

Measurement of progression of Gyrate Atrophy using Ultra-Wide Field fundus photography

Spectral Domain Optical Coherence Tomographic Analysis Of The Ocular Equator

Intravitreal Silicon-Based Quantum Dots as Neuroprotective Factors in a Model of Retinal Photoreceptor Degeneration

Non-mydriatic Single Filed Fundus Camera For Diabetic Retinopathy Screening: Assessment Of Efficacy, Prevalence And Risk Factors In A Safety Net Institution

Quantum Dots As Neuroprotective Factor In A Model Of Retinal Photoreceptor Degeneration

Ocular Biocompatibility of Nitinol Intraocular Clips

To View More...

You must be signed into an individual account to use this feature.